Discoveries in Chronic Kidney Disease

Discoveries in Chronic Kidney Disease

Source:

Stern L, et al. Abstract PUB316. Presented at: ASN Kidney Week; Nov. 2-7, 2021 (virtual meeting).

Disclosures: Stern reports commercial support for this presentation. Please see the study for all other authors’ relevant financial disclosures.
November 22, 2021
1 min read
Save

Gout significantly affects patients with advanced CKD

Source:

Stern L, et al. Abstract PUB316. Presented at: ASN Kidney Week; Nov. 2-7, 2021 (virtual meeting).

Disclosures: Stern reports commercial support for this presentation. Please see the study for all other authors’ relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

For patients with advanced chronic kidney disease, gout can significantly increase health care utilization and comorbidities, according to a study presented at ASN Kidney Week.

The study, presented by Leonard Stern, MD, a nephrologist at Columbia University Irving Medical Center in New York, found patients with CKD and uncontrolled gout faced increased health burdens, increased colchicine use and poorer toxicity profiles.

"Among CKD patients, gout is common, impactful and requires careful screening and collaborative management," Stern and colleagues wrote.

A total of 111 nephrologists provided chart data on patients with stage 3-5 CKD.

Of the 746 patients, 173 had gout. Patients with gout were further categorized having either controlled or uncontrolled gout. Overall, 13% had uncontrolled gout. Investigators compared results of patients with gout, patients with uncontrolled gout and patients without gout.

The comparison demonstrated patients with advanced CKD and gout more often required medical care and presented with symptoms, such as urination changes and shortness of breath, compared with patients without gout. Patients with gout also showed a greater rate of CKD-mineral bone disorder, ischemic heart disease, congestive heart failure, peripheral vascular disease and chronic pain.

In a comparison of patients with controlled gout vs. patients with uncontrolled gout, investigators found pulmonary hypertension, joint issues, chronic pain, febuxostat use and colchicine use were more common in patients with uncontrolled gout.